These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17266567)

  • 1. Biocatalytic approaches to optically active beta-blockers.
    Zelaszczyk D; Kieć-Kononowicz K
    Curr Med Chem; 2007; 14(1):53-65. PubMed ID: 17266567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [beta-Adrenergic receptor blockers--a group of chiral drugs: different effects of each enantiomer].
    Cizmáriková R
    Ceska Slov Farm; 2002 May; 51(3):121-8. PubMed ID: 12058352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Specific and nonspecific effects of beta receptor blockers: stereoselectively different properties exemplified by (R)- and (S)-propranolol].
    Stoschitzky K; Lindner W
    Wien Med Wochenschr; 1990 Apr; 140(6-7):156-62. PubMed ID: 1971978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoenzymatic Route for the Synthesis of (S)-Moprolol, a Potential β-Blocker.
    Ghosh S; Bhaumik J; Banoth L; Banesh S; Banerjee UC
    Chirality; 2016 Apr; 28(4):313-8. PubMed ID: 26821612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic Kinetic Resolution of Racemic 1-(Isopropylamine)-3-phenoxy-2-propanol: A Building Block for β-Blockers.
    Chałupka J; Marszałł MP; Sikora A
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biocatalytic approaches for the synthesis of optically pure vic-halohydrins.
    Xue F; Li C; Xu Q
    Appl Microbiol Biotechnol; 2021 May; 105(9):3411-3421. PubMed ID: 33851239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for enantiomer binding and separation of a common beta-blocker: crystal structure of cellobiohydrolase Cel7A with bound (S)-propranolol at 1.9 A resolution.
    Ståhlberg J; Henriksson H; Divne C; Isaksson R; Pettersson G; Johansson G; Jones TA
    J Mol Biol; 2001 Jan; 305(1):79-93. PubMed ID: 11114249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic resolution of 1-chloro-3-(1-naphthyloxy)-2-propanol, an intermediate in the synthesis of beta-adrenergic receptor blockers.
    Kapoor M; Anand N; Koul S; Chimni SS; Manhas KS; Raina C; Parshad R; Taneja SC; Qazi GN
    Bioorg Chem; 2003 Jun; 31(3):259-69. PubMed ID: 12818235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of chemical structure in stereoselective recognition of beta-blockers by cyclodextrins in capillary zone electrophoresis.
    Gagyi L; Gyéresi A; Kilár F
    J Biochem Biophys Methods; 2008 Apr; 70(6):1268-75. PubMed ID: 18022245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereochemical comparison of nebivolol with other beta-blockers.
    Siebert CD; Hänsicke A; Nagel T
    Chirality; 2008 Feb; 20(2):103-9. PubMed ID: 18072266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blockers of beta-adrenergic receptors--a group of chiral agents stereoselective synthesis of beta-blockers].
    Cizmáriková R; Valentová J; Hutt AJ; Sedláková S
    Ceska Slov Farm; 2005 Sep; 54(5):201-6. PubMed ID: 16209433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enantiocomplementary synthesis of β-adrenergic blocker precursors via biocatalytic nitration of phenyl glycidyl ethers.
    Wang HH; Wan NW; Da XY; Mou XQ; Wang ZX; Chen YZ; Liu ZQ; Zheng YG
    Bioorg Chem; 2023 Sep; 138():106640. PubMed ID: 37320911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocatalytic reduction of racemic 2-arenoxycycloalkanones by yeasts P. glucozyma and C. glabrata: one way of achieving chiral 2-arenoxycycloalcohols.
    Andreu C; Peña M; Del Olmo ML
    Appl Microbiol Biotechnol; 2016 Jun; 100(11):4865-73. PubMed ID: 26754816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoenzymatic enantioselective route to get (+) and (-) 4-acetoxy-azetidin-2-one by lipase-catalysed kinetic resolution and their applications.
    Martelli G; Cirillo M; Giraldi V; Giacomini D
    Bioorg Chem; 2022 Mar; 120():105580. PubMed ID: 35066318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-Adrenoreceptor antagonistic actions and mutagenicities of R(+)- and S(-)-enantiomers of N-desisopropylpropranolol and its N-acetyl conjugate.
    Ono Y; Wu X; Noda A; Noda H; Takeo S; Nasa Y; Isayama Y; Imai M; Sera N
    Biol Pharm Bull; 1997 Jan; 20(1):61-5. PubMed ID: 9013808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereochemical facets of clinical β-blockers: An overview.
    Vashistha VK; Kumar A
    Chirality; 2020 May; 32(5):722-735. PubMed ID: 32105373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromatographic resolution of chiral intermediates in beta-adrenergic blocker synthesis on chiral stationary phases.
    Ader U; Muschalek V; Schneider MP
    Chirality; 1993; 5(7):554-9. PubMed ID: 7902121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantioselective release of controlled delivery granules based on molecularly imprinted polymers.
    Suedee R; Srichana T; Rattananont T
    Drug Deliv; 2002; 9(1):19-30. PubMed ID: 11839205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans.
    Mehvar R; Brocks DR
    J Pharm Pharm Sci; 2001; 4(2):185-200. PubMed ID: 11466176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipase mediated new chemo-enzymatic synthesis of (RS)-, (R)-, and (S)-bunolol.
    Patlolla RR; Deepthi P; Raveena G; Rosangzuala K; Tejaswini S; Prakasham RS; Banoth L
    Chirality; 2024 Jan; 36(1):e23627. PubMed ID: 37957841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.